Recent Updates
Recently added Catalysts
NRXP Positive Sentiment

Dr. Jonathan Javitt, MD, MPH, Founder, Chairman, and Chief Scientist of NRx Pharmaceuticals presents at NobleCon21 – Noble Capital Markets’ Twenty First Annual Emerging Growth Equity Conference

Tuesday, December 9, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Dr. Jonathan Javitt, the Founder and Chief Scientist of NRx Pharmaceuticals, presented at NobleCon21, an annual conference focused on emerging growth equity. The event took place at Florida Atlantic University and aimed to connect innovative companies with potential investors. Javitt's participation underscores the company's commitment to advancing its pharmaceutical initiatives.
Price reaction · baseline $2.37 (2025-12-09T19:59:00.000Z) · hit during market hours · clean, no other NRXP news in the window
day 0 close · peak
-0.8%

Market Sentiment Analysis

POSITIVE FACTORS

  • Dr. Javitt's presentation highlights NRx Pharmaceuticals' innovations.
  • The conference provides a platform for emerging growth equity discussions.
  • Engagement at NobleCon21 showcases investor interest in NRx.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+167%
120-day peak, hindsight
Typical move
4.3%
average across 2 past catalysts
Cash runway
~12 mo
Low dilution risk
Lead asset
NRX-101
Phase 2 · Bipolar Depression

Full Press Release Details

Dr. Jonathan Javitt, MD, MPH, Founder, Chairman, and Chief Scientist of NRx Pharmaceuticals presents at NobleCon21 – Noble Capital Markets’ Twenty First Annual Emerging Growth Equity Conference at Florida Atlantic University, Executive Education Complex, in Boca Raton, FL

Frequently Asked Questions

What is NobleCon21?

NobleCon21 is an annual conference focused on emerging growth equity.

Who is Dr. Jonathan Javitt?

Dr. Jonathan Javitt is the Founder, Chairman, and Chief Scientist of NRx Pharmaceuticals.

Where was NobleCon21 held?

The conference took place at Florida Atlantic University in Boca Raton, FL.

What was the focus of Dr. Javitt's presentation?

Dr. Javitt's presentation highlighted innovations from NRx Pharmaceuticals.

ShareAdd on Google
Tags: NRXP Viatris Investor Conferences Healthcare Dr. Jonathan Javitt NobleCon21 emerging growth equity Florida Atlantic University
Last updated: Dec 9, 2025

Biotech snapshot

Cash runway
$27M liquidity · $2M/mo burn
~12 mo
Low dilution risk
Lead asset
NRX-101Phase 2
Bipolar Depression →

Catalyst track record

+167%
best trade around NRXP's most recent catalyst

Peak hindsight return over a 120-day window, across 2 tracked FDA/PDUFA catalysts for NRXP.

See every catalyst's timing & PoA →